HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses.

Abstract
Acute infection of humans with Ebola and Lassa viruses, two principal etiologic agents of hemorrhagic fevers, often results in a paradoxical pattern of immune responses: early infection, characterized by an outpouring of inflammatory mediators such as TNF-alpha, IL-1 beta, and IL-6, vs late stage infections, which are associated with poor immune responses. The mechanisms underlying these diverse outcomes are poorly understood. In particular, the role played by cells of the innate immune system, such as dendritic cells (DC), is not known. In this study, we show that Ebola and Lassa viruses infect human monocyte-derived DC and impair their function. Monocyte-derived DC exposed to either virus fail to secrete proinflammatory cytokines, do not up-regulate costimulatory molecules, and are poor stimulators of T cells. These data represent the first evidence for a mechanism by which Ebola and Lassa viruses target DC to impair adaptive immunity.
AuthorsSiddhartha Mahanty, Karen Hutchinson, Sudhanshu Agarwal, Michael McRae, Pierre E Rollin, Bali Pulendran
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 170 Issue 6 Pg. 2797-801 (Mar 15 2003) ISSN: 0022-1767 [Print] United States
PMID12626527 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Antigen Presentation (immunology)
  • Antigen-Presenting Cells (immunology, virology)
  • Cell Differentiation (immunology)
  • Cell Division (immunology)
  • Cells, Cultured
  • Dendritic Cells (immunology, virology)
  • Ebolavirus (immunology, pathogenicity)
  • Hemorrhagic Fever, Ebola (immunology, virology)
  • Humans
  • Immunity, Active (immunology)
  • Lassa Fever (immunology, virology)
  • Lassa virus (immunology, pathogenicity)
  • Monocytes (immunology, virology)
  • T-Lymphocyte Subsets (immunology, virology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: